0001209191-17-058481.txt : 20171031
0001209191-17-058481.hdr.sgml : 20171031
20171031181806
ACCESSION NUMBER: 0001209191-17-058481
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171031
FILED AS OF DATE: 20171031
DATE AS OF CHANGE: 20171031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 171166873
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-31
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, COO
Common Stock
2017-10-31
4
S
0
1700
142.40
D
114188
D
Common Stock
2017-10-31
4
S
0
5200
143.47
D
108988
D
Common Stock
2017-10-31
4
S
0
32945
144.47
D
76043
D
Common Stock
2017-10-31
4
S
0
22464
145.26
D
53579
D
Common Stock
2017-10-31
4
S
0
5200
146.39
D
48379
D
Common Stock
2017-10-31
4
S
0
3500
147.40
D
44879
D
Common Stock
2017-10-31
4
S
0
3791
148.26
D
41088
D
Common Stock
2017-10-31
4
S
0
200
149.34
D
40888
D
Common Stock
5306
I
401(k)
Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.75).
Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $143.47 (range $142.91 to $143.85).
Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.91 to $144.89).
Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87).
Open market sales reported on this line occurred at a weighted average price of $146.39 (range $145.30 to $146.92).
Open market sales reported on this line occurred at a weighted average price of $147.40 (range $146.93 to $147.90).
Open market sales reported on this line occurred at a weighted average price of $148.26 (range $147.93 to $148.70).
/s/ Omar White, Attorney-in-Fact
2017-10-31